Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits

Brain Research Bulletin

Volumn 81, Issue 2-3, 2010, Pages 248-255

  Zagon, I S ^a   Sassani, Joseph W ^a   Carroll, Melissa A ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cornea; Diabetes; Epithelium; Naltrexone; Wound healing

Indexed keywords

INSULIN; NALTREXONE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORNEAL REEPITHELIALIZATION; DIABETES CONTROL; DIABETIC KERATOPATHY; DRUG EFFICACY; EPITHELIZATION; EYE PHOTOGRAPHY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; KERATOPATHY; MALE; MORNING DOSAGE; NON INVASIVE MEASUREMENT; NONHUMAN; OCULOPLETHYSMOGRAPHY; PACHYMETRY; PRIORITY JOURNAL; RABBIT; SLIT LAMP; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CORNEAL DISEASES; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; ENKEPHALIN, METHIONINE; EPITHELIUM, CORNEAL; INTRAOCULAR PRESSURE; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RABBITS; REGENERATION; TIME FACTORS;

EID: 73149106360     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.10.009     Document Type: Article

References (50)

1. Azar D.T., Spurr-Michaud S.J., and Tisdale A.S. Altered epithelial-basement membrane interactions in diabetic corneas. Arch. Ophthalmol. 110 (1992) 537-540
2. Cavallerano J. Ocular manifestations of diabetes mellitus. Optom. Clin. 2 (1992) 93-116
3. Changolkar A.K., Hypolite J.A., Disanto M., Oates P.J., Alan J., and Chacko S. Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J. Urol. 173 1 (2005) 309-313
4. Waf1/Cip1pathways to restrict normal cell proliferation. Mol. Biol. Cell 20 1 (2009) 319-327
5. Cheng F., McLaughlin P.J., Verderame M.F., and Zagon I.S. Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation. Exp. Biol. Med. 234 (2009) 532-541
6. Chikama T., Wakuta M., Liu Y., and Nishida T. Deviated mechanism of wound healing in diabetic corneas. Cornea 26 Suppl. 1 (2007) S75-S81
7. Cisarik-Fredenburg P. Discoveries in research on diabetic keratopathy. Optometry 72 (2001) 691-704
8. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
9. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 (2005) 2643-2653
10. Fallucca F., Tonnarini G., Di Biase N., D'Alessandro M., and Negri M. Plasma met-enkephalin levels in diabetic patients: influence of autonomic neuropathy. Metabolism 45 (1996) 1065-1068
11. Friend J.C., Kiorpes T.C., and Thoft R.A. Diabetes mellitus and the rabbit corneal epithelium. Invest. Ophthalmol. Vis. Sci. 21 (1981) 317-321
12. Friend J., and Toft R.A. The diabetic cornea. Int. Ophthalmol. Clin. 24 (1984) 111-123
13. Greenberg J., Ellyin F., Pullen G., Ehrenpreis S., Singh S.P., and Cheng J. Methionine-enkephalin and β-endorphin levels in brain, pancreas, and adrenals of db/db mice. Endocrinology 116 (1985) 328-331
14. Hatchell D.L., Magolan J.J., Besson M.J., Goldman A.I., Perderson H.J., and Schultz K.J. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch. Ophthalmol. 101 3 (1983) 469-471
15. Hatchell D.L., Ubels J.L., Stekiel T., and Hatchell M.C. Corneal epithelial wound healing in normal and diabetic rabbits treated with tretinoin. Arch. Ophthalmol. 103 (1985) 98-100
16. Herse P.R. Recovery from contact lens-induced edema is prolonged in the diabetic rabbit cornea. Optom. Vis. Sci. 67 (1990) 466-470
17. Herse P.R. Diurnal and long-term variations in corneal thickness in the normal and alloxan-induced diabetic rabbit. Curr. Eye Res. 9 (1990) 451-457
18. Herse P.R. Corneal hydration control in normal and alloxan-induced diabetic rabbits. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2205-2213
19. Kabosova A., Kramerov A.A., Aoki A.M., Murphy G., Zierske J.D., and Ljubimov A.V. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp. Eye Res. 77 (2003) 211-217
20. Kaji Y. Prevention of diabetic keratopathy. Br. J. Ophthalmol. 89 (2005) 254-255
21. Klocek M.S., Sassani J.W., McLaughlin P.J., and Zagon I.S. Topically applied naltrexone restores corneal reepithelialization in diabetic rats. J. Ocul. Pharmacol. Ther. 23 (2007) 89-102
22. Klocek M.S., Sassani J.W., McLaughlin P.J., and Zagon I.S. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type 1 diabetic rats. Exp. Eye Res. 89 (2009) 686-692
23. Liebowitz H.M. Corneal Disorder. Clinical Diagnosis and Management (1984), Saunders, Philadelphia
24. Ljubimov A.V., Burgeson R.E., Butkowski R.J., Couchman J.R., Zardi L., Ninomiya Y., Sado Y., Huang Z.S., Nesburn A.B., and Kenney M.C. Basement membrane abnormalities in human eyes with diabetic retinopathy. J. Histochem. Cytochem. 44 (1996) 1469-1479
25. Ljubimov A.V., Huang Z., Huang G.H., Burgeson R.E., Gullberg D., Miner J.H., Ninomiya Y., Sado Y., and Kenney M.C. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J. Histochem. Cytochem. 46 (1998) 1033-1041
26. Negri M., Tonnarini G., D'Alessandro M., and Fallucca F. Plasma met-enkephalin in type 1 diabetes. Metabolism 41 (1992) 460-461
27. Saghizadeh M., Kramerov A.A., Tajbakhsh J., Aoki A.M., Wang C., Chai N.-N., Ljubimova J.Y., Sasaki T., Sosne G., Carlson M.R.J., Nelson S.F., and Ljubimov A.V. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Invest. Ophthamol. Vis. Sci. 46 (2005) 3604-3615
28. Sanchez-Thorin J.C. The cornea in diabetes mellitus. Int. Ophthalmol. Clin. 38 (1998) 19-36
29. Schratzberger P., Walter D.H., Rittig K., Bahlmann F.H., Pola R., Curry C., Silver M., Krainin J.G., Weinberg D.H., Ropper A.H., and Isner J.M. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107 9 (2001) 1083-1092
30. Schultz R.O., Iliev M.E., Frueh B.E., and Goldblum D. In vivo pachymetry in normal eyes of rats, mice, and rabbits with the optical low coherence reflectometer. Vis. Res. 43 6 (2003) 723-728
31. Schultz R.O., Van Horn D.L., Peters M.A., Klewin K.M., and Schutten W.H. Diabetic keratopathy. Trans. Am. Ophthalmol. Soc. 79 (1981) 180-199
32. Schulze S.D., Sekundo W., and Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am. J. Ophthalmol. 142 (2006) 207-211
33. Takahashi H., Akiba K., Noguchi T., Ohmura T., Takahashi R., Ezure Y., Ohara K., and Zieske J.D. Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition. Curr. Eye Res. 21 (2000) 608-615
34. Timmers K., Voyles N.R., Zalenski C., Wilkins S., and Recant L. Altered β-enkpehlain, met- and leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese (db/db) mice during development of diabetic syndrome. Diabetes 35 (1986) 1143-1151
35. Wakuta M., Morishige N., Chikama T., Seki K., Nagano T., and Nishida T. Delayed wound closure and phenotypic changes in corneal epithelium of the spontaneously diabetic Goto-Kakizaki rat. Invest. Ophthalmol. Vis. Sci. 48 (2007) 590-596
36. Wang P.Y. Control of hyperglycaemia in diabetic rabbits by a combination of implants. J. Biomed. Eng. 15 (1993) 106-112
37. Watanabe H., Katakami C., Miyata S., and Negi A. Corneal disorders in KKAy mouse: a type 2 diabetes model. Jpn. J. Ophthalmol. 46 (2002) 130-139
38. Weekers F., Giulietti A., Michalaki M., Coopmans W., Van Herch E., Mathieu C., and Van de Berghe G. Metabolic, endocrine, and immune effects on stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
39. Xu K.-P., Li Y., Ljubimov A.V., and Yu F.-S.X. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes 58 (2009) 1077-1085
40. Zagon I.S., Jenkins J.B., Sassani J.W., Wylie J.D., Ruth T.B., Frey J.L., Lang C.M., and McLaughlin P.J. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. Diabetes 51 10 (2002) 3055-3062
41. Zagon I.S., Klocek M.S., Sassani J.W., Mauger D.T., and McLaughlin P.J. Corneal safety of topically applied naltrexone. J. Ocul. Pharmacol. Ther. 22 5 (2006) 377-387
42. 5]-enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea. Brain Res. 671 (1995) 105-111
43. Zagon I.S., Sassani J.W., Kane E.R., and McLaughlin P.J. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor. Brain Res. 759 (1997) 92-102
44. Zagon I.S., Sassani J.W., and McLaughlin P.J. Opioid growth factor modulates corneal epithelial growth in tissue culture. Am. J. Physiol. 268 (1995) R942-R950
45. Zagon I.S., Sassani J.W., and McLaughlin P.J. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors. Brain Res. 798 (1998) 254-260
46. Zagon I.S., Sassani J.W., and McLaughlin P.J. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor. Brain Res. 803 (1998) 61-68
47. Zagon I.S., Sassani J.W., and McLaughlin P.J. Reepithelialization of the human cornea is regulated by endogenous opioids. Invest. Ophthalmol. Vis. Sci. 41 1 (2000) 73-81
48. Zagon I.S., Sassani J.W., and McLaughlin P.J. Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone. Cornea 25 7 (2006) 821-829
49. Zagon I.S., Sassani J.W., and McLaughlin P.J. Insulin treatment ameliorates impaired corneal re-epithelialization in diabetic rats. Diabetes 55 4 (2006) 1141-1147
50. Zagon I.S., Sassani J.W., Myers R.L., and McLaughlin P.J. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium. Brain Res. Bull. 72 1 (2007) 18-24